Beijing, China

Xianxing Shang

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 11.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xianxing Shang: Innovator in Pharmaceutical Chemistry

Introduction

Xianxing Shang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific protein activities.

Latest Patents

Xianxing Shang holds two patents that showcase his innovative work. The first patent involves an iminosulfanone compound that acts as a bromodomain protein inhibitor. This invention includes a preparation method, pharmaceutical composition, and medical applications. The second patent focuses on a compound represented by a specific formula that serves as an inhibitor of epidermal growth factor receptor (EGFR) activity. This disclosure relates to aniline pyrimidine derivatives and their pharmaceutical uses for treating diseases mediated by EGFR.

Career Highlights

Throughout his career, Xianxing Shang has worked with prominent companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Xianxing Shang has collaborated with several professionals in his field, including Yan Zhu and Ling Yang. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical chemistry.

Conclusion

Xianxing Shang is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and advancements in medical treatments. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…